In a recent prospective study, thirty patients were assessed using the QLQ-C30 score to evaluate their quality of life. The patients underwent hydrogen inhalation therapy for a duration of 2 weeks, and the results were remarkable.

Following the treatment, patients reported a reduction in dyspnea, indicating an improvement in their breathing. Additionally, they experienced an increase in appetite, suggesting a positive impact on their nutritional intake. The improvements extended beyond physical symptoms, as patients also demonstrated significant enhancements in their physical, role, and emotional functions. Fatigue, nausea, vomiting, and insomnia were noticeably reduced, contributing to an overall improvement in their daily functioning and well-being.

Continuing the treatment for 4 weeks yielded even more positive outcomes. Patients experienced substantial improvements in cognitive function, indicating enhanced mental clarity and sharpness. They also reported a significant reduction in pain levels, providing relief and a better overall sense of comfort. The treatment had a positive effect on gastrointestinal symptoms as well, with improvements observed in appetite, constipation, and diarrhea. These improvements can greatly contribute to the patients' overall quality of life and provide relief from distressing symptoms.

Hydrogen inhalation therapy has demonstrated its potential to improve various aspects of patients' lives, offering them relief from physical discomfort, emotional distress, and cognitive impairment. These findings emphasize the significant impact of hydrogen therapy on patients' well-being and provide hope for individuals seeking effective interventions to enhance their quality of life.

Source: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6779007/